Conflict of interest disclosure

Slides:



Advertisements
Similar presentations
Faculty/Presenter Disclosure Faculty: [name of speaker(s)] Relationships with commercial interests:  Grants/Research Support:  Speakers Bureau/Honoraria:
Advertisements

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.
Speaker Disclosure Explanation
Title of the presentation
Financial Disclosures Financial interests, arrangements or affiliations that could be perceived as a real or apparent “conflict of interest” in the context.
OU Neurology THE TITLE OF MY TALK John Doe, M.D. Professor Department of Neurology The University of Oklahoma Health Sciences Center.
Speaker Name: Disclosure of Relevant Financial Relationships
In My Practice: Asthma in Portugal
YOUR DISCLOSURE STATEMENT
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: - A conflict of interest is any situation.
The Patient Triage Concept: Right Diagnosis, Right Treatment
Faculty Disclosure Information
Neurological Clinicopathologic Case Presentation
Contemporary Paradigms for Anticoagulant Reversal
Managing symptomatic asthma in primary care: The personalised approach
2018 Canadian Transplant Summit - DISCLOSURE FORM
Novel approaches to TB infection control in private general hospitals in Georgia T Gabunia1, I Khonelidze, N Solomonia, T Merabishvili, M Makharadze,
Conflict of interest disclosure
Relevant Financial Disclosure(s)
Global programmatic use of bedaquiline and delamanid for drug-resistant TB treatment: progress, challenges, and possible solutions Dr. Vivian Cox Chair,
Speaker Disclosure slides for presentations
YOUR DISCLOSURE STATEMENT
Title of the presentation
Conflict of Interest Disclosure Form
Disclosure Information 87th Annual Scientific Meeting Speaker’s Name Here I have the following financial relationships to disclose: (select those that.
Continuing Medical Education Commercial Disclosure Requirement
Significant (greater than $10K)
Conflict of Interest Disclosure:
Disclosure Information 89th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.
Conflict of Interest Disclosure
Disclosure Information AACPDM 72nd Annual Meeting | October 9-13, 2018
<Title> <sub-title>
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
FIRST LAST Name Title of Session Title of Presentation.
Continuing Medical Education Commercial Disclosure Amedco, our CME provider, asks all individual involved in the development and presentation of Continuing.
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
FINANCIAL DISCLOSURES
Disclosure of conflicts of interest – explanation
Disclosure of Relevant Financial Relationships
Speaker Name: Disclosure of Relevant Financial Relationships
Talk Title 40pt Bold Calibri
Heading 40pt Calibri Body copy 24 pt Calibri.
Continuing Medical Education Commercial Disclosure Amedco, our CME provider, asks all individual involved in the development and presentation of Continuing.
Financial Disclosure Financial Interest / Affiliation
Disclosures Relevant financial relationships in the past twelve months by presenter or spouse/partner.    Employment: Company Name(s) Speakers Bureau:
Title of Talk Speaker name.
Talk Title 40pt Bold Calibri
Conflict of Interest Disclosure Form
Disclosure Information 90th Annual Scientific Meeting I have the following financial relationships to disclose: (select those that.
Disclosure of conflicts of interest
Speaker Name: Disclosure of Relevant Financial Relationships
Disclosure of conflicts of interest
Title of the presentation
MDR-TB Clinical Trials Landscape Overview: Current and Future Trials
Faculty/Presenter DISCLOSURE:
Clinical trial capacity building to address MDR-TB: challenges and the way forward
Conflict of Interest Disclosure , Salary: Royalty: Receipt of Intellectual Property Rights/Patent Holder: Consulting Fees.
Talk Title 40pt Bold Calibri
List disclosure information here.
Continuing Medical Education Commercial Disclosure Requirement
Financial Disclosure Financial Interest / Affiliation
Conflict of Interest Disclosure Form
Conflict of Interest Disclosures insert speaker’s name here
Continuing Medical Education Commercial Disclosure Amedco, our CME provider, asks all individual involved in the development and presentation of Continuing.
Conflict of Interest Disclosure Form DISCLOSURE
THE TITLE OF MY TALK John Doe, M.D. Professor Department of Neurology
< Title > < Sub-title >
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.
Conflict of Interest Disclosure Form
Presentation transcript:

Conflict of interest disclosure I have no, real or perceived, direct or indirect conflicts of interest that relate to this presentation. I have the following, real or perceived direct or indirect conflicts of interest that relate to this presentation: Affiliation / financial interest Nature of conflict / commercial company name Tobacco-industry and tobacco corporate affiliate related conflict of interest Grants/research support (to myself, my institution or department): Honoraria or consultation fees: Participation in a company sponsored bureau: Stock shareholder: Spouse/partner: Other support or other potential conflict of interest: This event is accredited for CME credits by EBAP and speakers are required to disclose their potential conflict of interest going back 3 years prior to this presentation. The intent of this disclosure is not to prevent a speaker with a conflict of interest (any significant financial relationship a speaker has with manufacturers or providers of any commercial products or services relevant to the talk) from making a presentation, but rather to provide listeners with information on which they can make their own judgment. It remains for audience members to determine whether the speaker’s interests or relationships may influence the presentation. Drug or device advertisement is strictly forbidden.